RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs
Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader...
News
Better Choice Announces Investment and Long-Term Partnership with World Series Champion Justin Turner and wife Kourtney Turner
NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer Reached Primary Endpoints in Phase III Clinical Study
SHANGHAI, China, April 22, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated...
Skye Bioscience Completes CMC and GLP Production for THCVHS Lead Program
Novel glaucoma drug ready for next development phase - GLP toxicology study – on critical path to first human clinical...
Dyadic International Hosting a Fireside Chat on “The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges”
Fireside Chat Being Held on Tuesday, May 4th @ 10am Eastern TimeJUPITER, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Dyadic...
ChemoCentryx to Hold First Quarter 2021 Financial Results Conference Call on Thursday, April 29, 2021
MOUNTAIN VIEW, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's first quarter...
OrthoPediatrics Corp. to Participate in the 7th Annual Truist Securities 2021 Life Sciences Summit
WARSAW, Ind., April 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on...
Celsion Management Participates in Alliance Global Partners Virtual Series
LAWRENCEVILLE, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and...
Ultragenyx Completes Successful End-of-Phase 2 Meeting with FDA and Finalizes Phase 3 Study Design for DTX301 Ornithine Transcarbamylase (OTC) Gene Therapy Program
Phase 3 Study on Track to Initiate in Second Half 2021NOVATO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical...
Maple Leaf Green World Inc. Has Created Its Own Brand Name – Phoenix Crave
CALGARY, Alberta, April 22, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”) (NEO: MGW,...
Radius Health Business Update
Growth of 14% for new U.S. TYMLOS® patients in Q1, 2021 vs. Q4, 2020Q1, 2021 TYMLOS net revenue impacted by...
The Center for Workforce Health and Performance and National Association of Worksite Health Centers Release Report to Help Employers and Insurers Manage Musculoskeletal Conditions
OAKLAND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Disability leaves for musculoskeletal conditions such as back pain and arthritis are...
Zogenix Presents New Data at Virtual AAN 2021 Showing Improved Executive Function in Lennox-Gastaut Syndrome (LGS) Patients Treated with FINTEPLA® (Fenfluramine) Oral Solution
LGS is one of the most challenging developmental and epileptic encephalopathies to manage because of high seizure frequency and significant...
Adaptimmune to Report Q1 2021 Financial Results and Business Update on Thursday, May 6, 2021
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 22, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy...
Gain Therapeutics Announces Presentation at the International Association of Parkinsonism and Related Disorders 2021 World Congress
Abstract highlighting Gain’s STAR candidate for Parkinson’s disease selected as one of the 10 Best Abstracts at the conferenceBETHESDA, Md.,...
X4 Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 6, 2021
BOSTON, April 22, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021
HAUPPAUGE, N.Y., April 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...
MiMedx to Host First Quarter 2021 Operating and Financial Results Conference Call on April 29
MARIETTA, Ga., April 22, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
Zenith Epigenetics Announces Clinical Collaboration with Astellas
To Evaluate the Combination of ZEN-3694 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate CancerCALGARY, Alberta, April 22, 2021 (GLOBE...
Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics
New collaboration mitigates risk in drug discovery process with artificial intelligence and in vitro “avatar” clinical trials CHERRY HILL, N.J.,...